HOME >> BIOLOGY >> NEWS
Only 21 states offer newborn screening tests recommended by March of Dimes

WHITE PLAINS, N.Y., JUNE 30, 2004 Seventy percent of babies born in the U.S. still fail to get the minimal number of newborn tests recommended by the March of Dimes, according to the non-profit's 2004 state-by-state report card on newborn screening.

The March of Dimes is the first national health organization to recommend that every baby born in the U.S. receive, at a minimum, screening for the same core group of nine metabolic disorders as well as hearing deficiency. The March of Dimes encourages states to add more screening tests as resources and capabilities allow.

Few parents realize that the extent of this testing depends entirely on the state in which their baby is born. These tests can sometimes mean the difference between a healthy start in life and disability, or even death, the March of Dimes says.

"The number of screened disorders continues to vary greatly by state. Here we have a simple and inexpensive solution to a potentially devastating problem, and it's time for all states to make newborn screening a top priority," says Dr. Jennifer L. Howse, president of the March of Dimes and a member of the U.S. Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children.

"Our chapter staff and volunteers have been working closely with governors, state legislators, and health departments to increase access to these important tests," Dr. Howse says. "I'm encouraged to report today that since this time last year, the number of states that test for the nine core metabolic disorders has risen from nine to 21."

Currently, 21 states screen for the March of Dimes-recommended list of metabolic disorders: Alaska, Connecticut, Hawaii, Idaho, Illinois, Indiana, Iowa, Maine, Maryland, Massachusetts, Mississippi, Nevada, New York, North Dakota, Oregon, Rhode Island, Tennessee, Vermont, Virginia, Washington, and Wisconsin. In 2002, these states accoun
'"/>

Contact: Michele Kling
mkling@marchofdimes.com
914-997-4613
March of Dimes Birth Defects Foundation
30-Jun-2004


Page: 1 2 3

Related biology news :

1. Alternative states in the ocean
2. Mathematical models reveal molten and glassy states of RNA
3. Not all enlarged prostates are the same, say University of Pittsburgh researchers
4. Canine leishmaniasis cases are confirmed in 21 states
5. Genetic extremism overstates risks
6. Lake research offers clues to managing crayfish invasions
7. Comparing primate genomes offers insight into human evolution
8. UW study: Migrating birds offer insight into sleep
9. Study of proteins offers insights into organization of biological networks
10. Susceptibility of mice to mousepox offers promise of smallpox protection
11. Discovery in parasite movement may offer insights into malaria

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Only states offer newborn screening tests recommended March Dimes

(Date:8/26/2015)... 26, 2015 The report "Multi-Factor Authentication ... Factor), Application (Travel & Immigration, Government, Banking, Defense, Commercial ... to 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is ... at a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual ... Solutions as number 1,361 in growth for the three years through 2014. Being named ... fastest-growing privately held organizations in the country. , “We are thrilled to make ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... recently presented new data on the relationship of genetics and hypertension at the ... on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
Cached News: